Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases

被引：38

作者：

Bogaert, Elike ^{[1
]}

Van Damme, Philip ^{[1
]}

Van Den Bosch, Ludo ^{[1
]}

Robberecht, Wim ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Neurobiol Lab, B-3000 Louvain, Belgium

来源：

MUSCLE & NERVE | 2006年 / 34卷 / 04期

关键词：

ALS; amyotrophic lateral sclerosis; motor neuron; neurodegeneration; neuroprotection; vascular endothelial growth factor; VEGF;

D O I：

10.1002/mus.20609

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The angiogenic activity of vascular endothelial growth factor (VEGF) is well known. Recently, it has become evident that VEGF is involved in central nervous system physiology and may play a role in the pathogenesis of neurological diseases. In particular, it may be involved in the mechanism of motor neuron degeneration in amyotrophic lateral sclerosis (ALS), and has been hypothesized to be implicated in the pathogenesis of peripheral neuropathies such as occur in the so-called POEMS syndrome and diabetes. VEGF is also being studied as a possible treatment option in some of these disorders. In this review we critically analyze the data supporting the notion that VEGF is a factor involved in motor neuron degeneration and review the studies linking VEGF to other diseases of the peripheral and central nervous systems.

引用

页码：391 / 405

页数：15

共 144 条

[1] VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model [J].

Azzouz, M ;

Ralph, GS ;

Storkebaum, E ;

Walmsley, LE ;

Mitrophanous, KA ;

Kingsman, SM ;

Carmeliet, P ;

Mazarakis, ND .

NATURE, 2004, 429 (6990) :413-417

[2] Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor [J].

Bagnard, D ;

Vaillant, C ;

Khuth, ST ;

Dufay, N ;

Lohrum, M ;

Püschel, AW ;

Belin, MF ;

Bolz, J ;

Thomasset, N .

JOURNAL OF NEUROSCIENCE, 2001, 21 (10) :3332-3341

[3] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].

Barleon, B ;

Sozzani, S ;

Zhou, D ;

Weich, HA ;

Mantovani, A ;

Marme, D .

BLOOD, 1996, 87 (08) :3336-3343

[4] Regulation of vascular permeability by vascular endothelial growth factors [J].

Bates, DO ;

Harper, SJ .

VASCULAR PHARMACOLOGY, 2002, 39 (4-5) :225-237

[5] Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias [J].

Blasko, I ;

Lederer, W ;

Oberbauer, H ;

Walch, T ;

Kemmler, G ;

Hinterhuber, H ;

Marksteiner, J ;

Humpel, C .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 21 (01) :9-15

[6]

Bongioanni P, 2004, Cochrane Database Syst Rev, pCD004302, DOI 10.1002/14651858.CD004302.pub2

[7] A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis [J].

Borasio, GD ;

Robberecht, W ;

Leigh, PN ;

Emile, J ;

Guiloff, RJ ;

Jerusalem, F ;

Silani, V ;

Vos, PE ;

Wokke, JHJ ;

Dobbins, T .

NEUROLOGY, 1998, 51 (02) :583-586

[8] COORDINATE EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR-1 (FLT-1) AND ITS LIGAND SUGGESTS A PARACRINE REGULATION OF MURINE VASCULAR DEVELOPMENT [J].

BREIER, G ;

CLAUSS, M ;

RISAU, W .

DEVELOPMENTAL DYNAMICS, 1995, 204 (03) :228-239

[9] Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis [J].

Brockington, A ;

Wharton, SB ;

Fernando, M ;

Gelsthorpe, CH ;

Baxter, L ;

Ince, PG ;

Lewis, CE ;

Shaw, PJ .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (01) :26-36

[10] Unraveling the mechanisms involved in motor neuron degeneration in ALS [J].

Bruijn, LI ;

Miller, TM ;

Cleveland, DW .

ANNUAL REVIEW OF NEUROSCIENCE, 2004, 27 :723-749

← 1 2 3 4 5 6 7 8 9 10 →